Literature DB >> 8772716

Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function.

A M Davalli1, L Scaglia, D H Zangen, J Hollister, S Bonner-Weir, G C Weir.   

Abstract

To learn more about islet vulnerability in the immediate posttransplant period, 400 syngeneic islets were transplanted under the kidney capsule of B6AF1 mice. Three groups of recipients were used: normal mice (normal), streptozotocin (STZ)-diabetic (diabetic), and STZ-diabetic kept hypo- or normoglycemic with insulin pellets (diabetic-normalized). Normoglycemia was achieved in all three groups 14 days after transplantation; however, in the diabetic and diabetic-normalized groups, blood glucose levels throughout the posttransplantation period were respectively higher and lower than in the normal group. Grafts were harvested 1, 3, 7, and 14 days after transplantation and analyzed for morphology, beta-cell death, beta-cell mass, insulin content, and insulin mRNA expression. In all groups, substantial damage in islet grafts was found on days 1 and 3 with apoptotic nuclei and necrotic cores; on day 3, beta-cell death was significantly higher in the diabetic group than in the other groups. Tissue remodelling occurred in all groups with stable graft appearance on day 14; the actual beta-cell mass of the grafts was lowest in the diabetic group. Graft insulin content decreased in all groups on day 1 and fell even further on days 3 and 7. Insulin mRNA levels of grafts retrieved from both the diabetic and diabetic-normalized group were lower than those from the normal group already by day 1 and remained lower on day 14. In conclusion, the first few days of islet transplantation, even under the most advantageous circumstances of excellent metabolic control, are characterized by dynamic changes, with substantial islet cell dysfunction and death followed by tissue remodelling and then stable engraftment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8772716     DOI: 10.2337/diab.45.9.1161

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  131 in total

Review 1.  Ischaemia is linked to inflammation and induction of angiogenesis in pancreatic islets.

Authors:  T Linn; J Schmitz; I Hauck-Schmalenberger; Y Lai; R G Bretzel; H Brandhorst; D Brandhorst
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  Monitoring neovascularization of intraportal islet grafts by dynamic contrast enhanced magnetic resonance imaging.

Authors:  Nathaniel K Chan; Andre Obenaus; Annie Tan; Naoaki Sakata; John Mace; Ricardo Peverini; Richard Chinnock; Lawrence C Sowers; Eba Hathout
Journal:  Islets       Date:  2009-11       Impact factor: 2.694

Review 3.  Enhancing clinical islet transplantation through tissue engineering strategies.

Authors:  Jaime A Giraldo; Jessica D Weaver; Cherie L Stabler
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

4.  Synthesis of multilayered alginate microcapsules for the sustained release of fibroblast growth factor-1.

Authors:  Omaditya Khanna; Monica L Moya; Emmanuel C Opara; Eric M Brey
Journal:  J Biomed Mater Res A       Date:  2010-11       Impact factor: 4.396

5.  No islets left behind: islet autotransplantation for surgery-induced diabetes.

Authors:  Melena D Bellin; A N Balamurugan; Timothy L Pruett; David E R Sutherland
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

6.  Efficient Gene Transduction of Dispersed Islet Cells in Culture Using Fiber-Modified Adenoviral Vectors.

Authors:  Hiroyuki Hanayama; Kazuo Ohashi; Rie Utoh; Hirofumi Shimizu; Kazuya Ise; Fuminori Sakurai; Hiroyuki Mizuguchi; Hiroyuki Tsuchiya; Teruo Okano; Mitsukazu Gotoh
Journal:  Cell Med       Date:  2015-08-26

7.  Delayed revascularization of islets after transplantation by IL-6 blockade in pig to non-human primate islet xenotransplantation model.

Authors:  Byoung-Hoon Min; Jun-Seop Shin; Jong-Min Kim; Seong-Jun Kang; Hyun-Je Kim; Il-Hee Yoon; Su-Kyoung Park; Ji-Won Choi; Min-Suk Lee; Chung-Gyu Park
Journal:  Xenotransplantation       Date:  2017-12-06       Impact factor: 3.907

8.  Human blood outgrowth endothelial cells improve islet survival and function when co-transplanted in a mouse model of diabetes.

Authors:  V Coppens; Y Heremans; G Leuckx; K Suenens; D Jacobs-Tulleneers-Thevissen; K Verdonck; T Lahoutte; A Luttun; H Heimberg; N De Leu
Journal:  Diabetologia       Date:  2012-10-23       Impact factor: 10.122

9.  Reversal of hyperglycemia in diabetic mice by a marginal islet mass together with human blood outgrowth endothelial cells is independent of the delivery technique and blood clot-induced processes.

Authors:  Violette Coppens; Yves Heremans; Gunter Leuckx; Krista Suenens; Daniel Jacobs-Tulleneers-Thevissen; Kristoff Verdonck; Aernout Luttun; Harry Heimberg; Nico De Leu
Journal:  Islets       Date:  2013-11-08       Impact factor: 2.694

10.  Differential expression and release of exosomal miRNAs by human islets under inflammatory and hypoxic stress.

Authors:  Prathab Balaji Saravanan; Srividya Vasu; Gumpei Yoshimatsu; Carly M Darden; Xuan Wang; Jinghua Gu; Michael C Lawrence; Bashoo Naziruddin
Journal:  Diabetologia       Date:  2019-08-01       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.